Seattle-based biotech Kineta Inc. was founded on the principle of getting faster returns for investors — without selling the company.
Now the company is taking another new approach to the biotech business, joining an international partnership that brings together the capital and expertise of five different biotechs in a new company, called KPI Therapeutics.
Kineta built its model around offering investors a chance to see a return in three to five years, instead of the typical 10 to 20 years.…
Seattle-based biotech Kineta Inc. was founded on the principle of getting faster returns for investors — without selling the company.
Now the company is taking another new approach to the biotech business, joining an international partnership that brings together the capital and expertise of five different biotechs in a new company, called KPI Therapeutics.
Kineta built its model around offering investors a chance to see a return in three to five years, instead of the typical 10 to 20 years.…